Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Medarex Gets Approval For MDX-1338
The Phase 1, dose-escalation study of MDX-1338 as a monotherapy with chemotherapy is expected to enroll up to 34 patients with relapsed/ refractory AML. Moreover, this trial is
The Phase 1, dose-escalation study of MDX-1338 as a monotherapy with chemotherapy is expected to enroll up to 34 patients with relapsed/ refractory AML. Moreover, this trial is
The company claims that AstraZeneca and its wholly-owned subsidiary, Tika have disregarded their obligations under the three agreement with Verus signed in 2007. Under the terms of the
“As part of a continuing effort to be the imaging provider in the New England market, Shields senior management developed an optimization strategy for the operation of all
Sanofi will initiate the development process called passaging, which will yield a working seed for the vaccine. Passaging is the process to acclimate virus to grow in a
MuGard forms a protective coating over the oral mucosa when swirled gently around the mouth. In a comparison of cancer patients receiving standard mucositis care with those patients
The draft guidance discusses factors that are relevant to the 22 disclosure of risk information and provides numerous examples to illustrate FDA’s thinking on these 23 factors. This
ProTrials will direct the Huntington’s trial across the US, Canada and Europe. Moreover, the company will also manage prostate cancer trial in the US and Canada. Jodi Andrews,
Sciele will share development costs for PSD502 for non-US territories and pay royalties to Plethora on non-US revenues. Ed Schutter, President and COO, Sciele Pharma, said: “we are
Originally, 11% was planned. The current sales and cost projection until the end of fiscal year 2009 is the basis for this change. Moreover, the management board with
Taxus Express Atom Stent offers an alternative treatment choice for patients with small vessels who will now have the additional option of the Taxus Liberte Atom Stent. Mark